Tag: AcQMap

Acutus Medical Announces Approval of its AcQMap System and AcQMap 3D Imaging and Mapping Catheter in Japan

Approval ushers in a new era of arrhythmia management in Japan through revolutionary non-contact imaging and diagnosis technology CARLSBAD, Calif., July 27, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced approval of its AcQMap High Resolution […]

Acutus Medical Announces FDA Clearance of Second-Generation AcQMap 3D Imaging & Mapping Catheter

Design Features Improve Handling and Deliverability to Enhance Efficiency CARLSBAD, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) — Acutus Medical (Nasdaq: AFIB) today announces FDA 510(k) clearance of the second-generation AcQMap® 3D imaging and mapping catheter which builds on its predecessor, improving handling and deliverability. This flagship 3D mapping and navigation catheter combines 48 ultrasound transducers responsible for […]

Acutus Medical Announces $170 Million Financing

CARLSBAD, Calif., June 20, 2019 /PRNewswire/ — Acutus Medical today announced a $170 million financing, including a $100 million Series D equity financing and a $70 million credit facility. The funding is intended to accelerate commercialization and facilitate global business development activities as the company continues to transform arrhythmia care through distinct, innovative technologies designed to provide physicians and patients with improved results. The Series […]

Acutus Medical’s New Contact Mapping Software Receives CE Mark

CARLSBAD, Calif. and MANNHEIM, Germany, April 26, 2019 /PRNewswire/ — Acutus Medical today announced CE mark approval for AcQMap contact mapping software, offering expanded functionality that provides physicians with more options to inform individualized patient therapy. The company also announced FDA clearance of its second generation AcQMap platform. All AcQMap systems retain the unique ability to quickly reconstruct atrial anatomy using […]

Foundational Publication Validates Acutus AcQMap System’s Breakthrough Non-Contact Technology

CARLSBAD, Calif., March 25, 2019 /PRNewswire/ — Acutus Medical today announced the publication of “High Resolution Non-Contact Charge Density Mapping of Endocardial Activation” in JCI Insight. This foundational manuscript indicates that charge mapping enables unmatched visualization of the conduction patterns and localized non-pulmonary vein (PV) therapeutic targets in patients with atrial arrhythmias, such as atrial fibrillation (AF). Investigators examined clinical […]

AF Symposium 2019: Acutus AcQMap Imaging System Helps Physicians Eliminate Arrhythmia with a Single Ablation

CARLSBAD, Calif., Jan. 28, 2019 /PRNewswire/ — Acutus Medical today announced 12-month data from the UNCOVER-AF trial investigating the use of the AcQMap advanced cardiac imaging and mapping visualization system in persistent atrial fibrillation (AF) ablation procedures. Results presented at the 24th Annual AF Symposium in Boston show the use of AcQMap resulted in 72.5 percent single-procedure freedom from AF at […]

AF Symposium 2019: Acutus Medical Announces Presentation of Late-Breaking Data Reinforcing Benefit of Non-Contact Cardiac Mapping

CARLSBAD, Calif., Jan. 22, 2019 /PRNewswire/ — Acutus Medical will highlight the benefits of its AcQMap advanced cardiac imaging and mapping visualization system at AF Symposium January 24-26 in Boston. The AcQMap system enables physicians to have a more precise approach to strategically address atrial arrhythmias by uncovering the true electrical activation pattern of the heart in real time. Physicians can see […]

First Cardiac Procedure Using the AcQMap® System by Acutus Medical® Successfully Performed in the United States

CARLSBAD, Calif., May 8, 2018 /PRNewswire/ — Acutus Medical®, a global heart rhythm technology company, today announced that the AcQMap® High Resolution Imaging and Mapping System has been utilized for the first time in U.S. patients. The company also revealed initiation of a new clinical study to evaluate the technology during atrial fibrillation retreatment ablation procedures in Europe and Canada. “Enabling physicians […]